4 Indian Pathologists recognised in Stanford University 2026 world's Top 2% Scientists List
New Delhi: This year, a total of 4 pathologists from India's various prestigious health and medical institutes have been recognised among the world's top 2% of scientists in the prestigious database curated by Professor John P.A. Ioannidis of Stanford University, in collaboration with the Elsevier Data Repository..
Being recognised in Stanford University's top 2% list of scientists acknowledges their pioneering research, clinical achievements, and consistent impact on the field.
Stanford University's 2026 database of top-cited scientists provides standardised information on citations, h-index, co-authorship-adjusted h-index, citations to papers in different authorship positions, and a composite indicator (c-score). The selection is based on the top 100,000 scientists by c-score (with and without self-citations) or a 2% or above percentile rank in the sub-field.
Altogether, 4 Indian pathologists have been featured in Stanford University's list for 2026. Their research subfield is Pathology. Below are their details:
(1) Dr Deepali Jain - AIIMS, New Delhi:
Dr. Jain is a pathologist at All India Institute of Medical Sciences (AIIMS), New Delhi, and she specialises in Thoracic Pathology and Cytopathology. Since June 2025, she has been working as a Professor of Thoracic Pathology at the Center of Excellence, University of Pittsburgh Medical Center (UPMC), Pittsburgh, USA, while continuing her position at AIIMS, New Delhi. She pursued her MBBS from Gajra Raja Medical College and MD Pathology from PGIMER, Chandigarh.
Her academic and research interests focus on lung cancer, sinonasal cancer, and thymic tumours. She has received several awards, including the AIIMS Oncology Research Award in 2020 and 2021, the Mary J. Matthews Pathology/Translational Research Award from IASLC in 2021, the DST SERB Women POWER fellowship in 2021, and multiple fellowships and honours such as FRCPath, FIAC, and the IASLC International Mentorship Award.
She has been recognised as one of the top 2% scientists across the world, as per Stanford University's list of 2026. She holds a rank of 73398 in the list based on the composite score excluding self-citations, and 67461 when all citations are included. By the end of 2025, her h-index, excluding self-citations, stands at 14, with a total of 1,490 citations for 2025 (excluding self-citations).
Her main field of research is Clinical Medicine; subfield 1 is Pathology, and subfield 2 is Oncology and Carcinogenesis.
In 2025, Dr. Jain held a rank of 66,044 in Stanford University's list based on the composite score excluding self-citations, and 64,310 when all citations were included. By the end of 2024, her h-index, excluding self-citations, was 14, with altogether 1,360 citations for 2024 (excluding self-citations).
She is a member of committees like the ICCR Thymic Epithelial Tumours dataset authoring committee and serves on editorial boards, including the upcoming IAC-IARC International System for Reporting Lung Cytopathology and the WHO classification of thoracic tumours. Dr Deepali has published books and chapters, including the “Atlas of Thymic Pathology” and 40 book chapters in major WHO classifications.
(2) Dr Pranab Dey - Homi Bhabha Cancer Hospital & Research Center:
A former Professor of Cytology at Post Graduate Institute of Medical Education and Research (PGIMER), Dr. Pranab Dey has devoted more than three decades to research, reporting and teaching. He is currently associated with Homi Bhabha Cancer Hospital & Research Center, Punjab.
Dr. Dey pursued his MBBS from RG Kar Medical College, Kolkata, and MD from PGIMER. He has published 13 books on cytology, gynaecologic pathology, and laboratory techniques and is considered one of the leading authors of pathology. He contributed significant original research works (more than 500). Dr Dey has an intense interest in artificial intelligence and has published several research papers in this area over the last two decades.
Dr Dey has been recognised as one of the top 2% scientists across the world, as per Stanford University's list of 2026. He holds a rank of 106458 in the list based on the composite score excluding self-citations, and 109854 when all citations are included. By the end of 2025, his h-index, excluding self-citations, stands at 8, with altogether 343 citations for 2025 (excluding self-citations).
His main field of research is Clinical Medicine; subfield 1 is Pathology, and subfield 2 is Oncology and Carcinogenesis
In 2025, Dr. Dey held a rank of 112,423 in the Stanford list based on the composite score excluding self-citations, and 111,809 when all citations were included. By the end of 2024, his h-index, excluding self-citations, stood at 7, with altogether 339 citations for 2024 (excluding self-citations).
(3) Dr Bharat Rekhi- Tata Memorial Hospital:
A renowned pathologist. Dr. Bharat Rekhi is a Professor at Tata Memorial Centre (TMC), Mumbai, with a special interest in bone and soft tissue tumours (adult and pediatric), gynec pathology and related molecular and cytopathology. Dr. Rekhi is the Editor-in-chief of the Indian Journal of Pathology & Mircobiology (IJPM).
He has many awards to his credit, three gold medal orations and presented at National and International Conferences, including European Congress of Pathology(ECP), International Congress of Cytology (ICC), European Congress of Cytology (ECC), IAP-Asia Pacific, USCAP, ESMO-Asia 2019 (Invited speaker) and NUHS surgical pathology course, Singapore, 2019 and sarcoma preceptorship course, Singapore.
Dr. Rekhi has been recognised as one of the top 2% scientists across the world, as per Stanford University's list of 2026. He holds a rank of 221763 in the list based on the composite score excluding self-citations, and 229657 when all citations are included. By the end of 2025, his h-index, excluding self-citations, stands at 6, with altogether 305 citations for 2025 (excluding self-citations).
His main field of research is Clinical Medicine; subfield 1 is Pathology and subfield 2 is oncology and carcinogenesis.
In 2025, he held a rank of 287,697 in the Stanford list based on the composite score excluding self-citations, and 257,356 when all citations were included. By the end of 2024, his h-index, excluding self-citations, was 6, with altogether 266 citations for 2024 (excluding self-citations).
He pursued his MBBS and MD Pathology from PGIMS Rohtak, followed by DNB Pathology from SRMCRI Chennai, and MRC Path-Part I from GMC Mumbai, India.
Dr. Rekhi has been an editorial board member of IJPM since 2018 and associate editor of IJPM since 2019. He has been the Co-editor for the first special issue of IJPM (Gynec Section). He has been invited as faculty/Speakerin various CMEs during APCON Conferences and moderated IAP-ID Slide seminar in 2014.
(4) Dr Nalini M. Gupta- Postgraduate Institute of Medical Education and Research, Chandigarh:
Dr. Gupta is a Professor and Head of the Department of Cytology and Gynaecological Pathology at PGIMER, Chandigarh. She completed her MBBS and MD (Pathology) from Government Medical College, Amritsar, and holds a DNB (Pathology) from the National Board of Examinations. She also trained as a Senior Resident in Pathology at PGIMER, Chandigarh, and received six months of specialised training in the U.K. in Liquid-Based Cytology for gynaecological and non-gynaecological samples, including HPV typing.
Her primary areas of interest include fine needle aspiration cytology, gynaecological cytology, and cancer research, particularly in carcinoma cervix, lung, and head and neck cancers. She has led and contributed to several research projects, including studies on endometrial carcinoma biomarkers, HPV and EBV detection, and immunochemistry in various cancers. Her ongoing research focuses on EGFR mutations in non-small cell lung cancer, biological markers in endometrial carcinoma, and HPV screening among female sex workers in Chandigarh.
Prof. Gupta specialises in fine needle aspiration cytology, liquid-based cytology, and ancillary techniques applicable to cytology samples. She is a life member of several prestigious professional bodies, including the Indian Association of Pathologists and Microbiologists, National Academy of Medical Sciences, Indian Academy of Cytologists, and Indian Society for the Study of Lung Cancer. She has over 140 publications in national and international peer-reviewed journals.
She has been recognised as one of the top 2% scientists across the world, as per Stanford University's list of 2026. She holds a rank of 242910 in the list based on the composite score excluding self-citations, and 247418 when all citations are included. By the end of 2025, her h-index, excluding self-citations, stands at 7, with altogether 351 citations for 2025 (excluding self-citations).
Her main field of research is Clinical Medicine; subfield 1 is Pathology and subfield 2 is oncology and carcinogenesis.
In 2025, she held a rank of 203,900 in the Stanford list based on the composite score excluding self-citations, and 197,793 when all citations were included. By the end of 2024, her h-index, excluding self-citations, was 6, with altogether 339 citations for 2024 (excluding self-citations).
